On May 20 in Houston, TX, we will be hosting our first mesothelioma conference as part of the 2016 International Symposium on Malignant Mesothelioma. The…
by Janet Graeff As of March 14, 2016, my daughter is 10 years NED, no evidence of disease. She is a peritoneal mesothelioma survivor. I…
Throughout February, we posted blogs about how to host your own fundraising event, the importance of event sponsors, and how to sustain your audience. We’re…
by Maja Belamaric, Director of Communications, Mesothelioma Applied Research Foundation A few months ago, I logged into my Facebook account as I always do first…
You can now register to attend the Meso Foundation’s 2016 International Symposium on Malignant Mesothelioma in Houston, San Francisco, and Chicago. We understand that for…
Just today, we learned that Verastem, a biotech company that has previously done research in mesothelioma, has now embarked on several new projects. In the…
The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma. In an AstraZeneca press release issued…
by Missy Bowles, Fundraise for Meso Event Planner I started RODs Benefit for Meso a year after I lost my daddy to peritoneal mesothelioma. It…
By Erin Wojno, Fundraise for Meso Event Planner Sponsorships are a key factor in the success of a Fundraise for Meso fundraiser. Our first 5K…
In the first of a special two-part series of Meet the Mesothelioma Experts, we interview our 2015 mesothelioma research grant recipients. In this session, we…









